Joykem ODT 50 Tablet contains Amisulpride 50 mg, an atypical antipsychotic agent primarily indicated for the treatment of schizophrenia and other psychotic disorders. Amisulpride acts by selectively blocking dopamine D2 and D3 receptors in the brain, which helps to restore the balance of neurotransmitters and alleviate symptoms such as hallucinations, delusions, and thought disorders. The orally disintegrating tablet (ODT) formulation facilitates ease of administration, particularly for patients with swallowing difficulties or poor compliance. Joykem ODT 50 is typically prescribed for both acute and maintenance therapy in schizophrenia, improving both positive and negative symptoms. The medication should be used under strict medical supervision, with dosage adjustments based on clinical response and tolerability. Common side effects may include extrapyramidal symptoms, weight gain, sedation, and increased prolactin levels, which require monitoring during treatment. Caution is advised in patients with a history of cardiac disorders, seizures, or renal impairment. Joykem ODT 50 should not be abruptly discontinued to avoid withdrawal symptoms or relapse. It is contraindicated in individuals with hypersensitivity to Amisulpride or related compounds. Regular follow-up is essential to assess therapeutic efficacy and adverse effects, ensuring optimal patient outcomes.